Coral Laboratories MD, chairman, board of directors and AGM
BSE: 524506Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹506.95.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹177 Cr2,551st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 20 Oct 2026
- 9.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 Sep 2026
- 0.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.40%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 20 Oct 2026
- 9.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 20 Oct 2026
- 7.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 Sep 2026
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,855
Coral Laboratories board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonSUSHMA KADKADE
- Company Secretary and Compliance OfficerDiwakar Menon
6 directors3 independent1 executive2 non-executive
- GIRISH DHAMEJAExecutive · joined May 2017 · reappointed May 2023 · 40 months as independent · 1 listed board
- SUSHMA KADKADE · ChairpersonNon-executive · joined May 2017 · 112 months as independent · 1 listed board · 2 committee seats
- SAURABH SHAHIndependent · joined Sep 2019 · reappointed May 2024 · 28 months as independent · 1 listed board · 1 as independent · 2 committee seats
- MALAY DOSHIIndependent · joined May 2021 · reappointed May 2026 · 64 months as independent · 1 listed board · 1 as independent · 2 committee seats, 2 as chair
- RAJENDRASINH RANANon-executive · joined Sep 2021 · 61 months as independent · 1 listed board
- POOJA HINDIAIndependent · joined Aug 2024 · 26 months as independent · 1 listed board · 1 as independent
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 24 Sep 20266 of 6 present3 independent · 40 days in between
- 14 Aug 20266 of 6 present3 independent · 56 days in between
- 18 Jun 20266 of 6 present3 independent · 18 days in between
- 30 May 20266 of 6 present3 independent · 36 days in between
2 earlier meetings
- 23 Apr 20266 of 6 present3 independent · 20 days in between
- 2 Apr 20266 of 6 present3 independent
Audit Committee
Chair MALAY DOSHI
SUSHMA KADKADE, SAURABH SHAH
- 24 Sep 20263 of 3 present2 independent · 40 days in between
- 14 Aug 20263 of 3 present2 independent · 56 days in between
- 18 Jun 20263 of 3 present2 independent · 18 days in between
- 30 May 20263 of 3 present2 independent · 57 days in between
1 earlier meeting
- 2 Apr 20263 of 3 present2 independent
Nomination and remuneration committee
Chair MALAY DOSHI
SUSHMA KADKADE, SAURABH SHAH
- 14 Aug 20263 of 3 present2 independent · 56 days in between
- 18 Jun 20263 of 3 present2 independent · 55 days in between
- 23 Apr 20263 of 3 present2 independent · 20 days in between
- 2 Apr 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair MALAY DOSHI
SUSHMA KADKADE, SAURABH SHAH
- 14 Aug 20263 of 3 present2 independent · 75 days in between
- 30 May 20263 of 3 present2 independent
Corporate Social Responsibility Committee
Chair MALAY DOSHI
SUSHMA KADKADE, SAURABH SHAH
- 18 Jun 20263 of 3 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- S C Mehra & Associates LLPPeer-review certificate valid to Mar 2027
1 earlier auditor
- M.A. Parekh & AssociatesNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Coral Laboratories AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Coral Laboratories dividend history
Annual general meeting, 29 Sep 2026
4,007 shareholders on the register on 22 Sep 2026; present: 2 promoters and 18 others; votes counted by Raju Ananthanarayanan / SARK & Associates LLP.The company's voting result (opens in a new tab)
- Consideration and adoption of the audited standalone financial statements of the company for the financial year ended March 31, 2026 and the reports of the board of directors and auditors thereonOrdinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 75.12% · promoters 100.00% · other public 12.67%
- Declaration of dividend on equity sharesOrdinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 75.12% · promoters 100.00% · other public 12.67%
- Re-appointment of Mrs. Sushma Kadkade, as Director liable to retire by rotationOrdinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 75.12% · promoters 100.00% · other public 12.67%
- Re-appointment of Mr. Rajendrasinh Rana, as a Director liable to retire by rotationOrdinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 75.12% · promoters 100.00% · other public 12.67%
- Ratification of remuneration of Cost Auditor of the Company for the year 2026-27Ordinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 75.12% · promoters 100.00% · other public 12.67%
- Approval of remuneration to Mrs. Sushma Kadkade, Non-Executive Director of the companySpecial98.48% for1.52% against
Against: promoters 0.00% · other public 31.62%
Turnout: all 75.12% · promoters 100.00% · other public 12.67%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Tax disputes
Reported in the filing for the quarter to Sep 2026.
- Tax disputeDeputy Commissioner Jurisdiction : GST Vikas Nagar - Sector 1:Dehradun:Uttarakhand, State/UT : UttarakhandSince 11 Oct 2022PendingAt the filing before: We have filled Appeal against the order u/s 74 for GST ITC credit claimed F.Y. 2017-18
- Tax disputeMicro and Small Enterprises Facilitation Council (MSEFC), SuratSince 27 Apr 2026PendingAt the filing before: Notice received in a reference filed under Section 18 of the MSMED Act, 2006 for alleged non-receipt of payments.
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- No
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.